↓ Skip to main content

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series

Overview of attention for article published in Frontiers in oncology, October 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

twitter
43 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
12 Mendeley